MRI of the breast has the highest sensitivity for breast cancer detection among current
clinical imaging modalities and is indispensable for breast imaging practice. While the basis …

Physiological properties of tumors can be measured both in vivo and noninvasively by
diffusion‐weighted imaging and dynamic contrast‐enhanced magnetic resonance imaging …

The diagnosis and management of breast cancer are undergoing a paradigm shift from a
one-size-fits-all approach to an era of personalized medicine. Sophisticated diagnostics …

In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI),
gadopentetate dimeglumine (Magnevist®), became available for clinical use. Since then, a …

Purpose We investigated whether an abbreviated protocol (AP), consisting of only one pre-
and one postcontrast acquisition and their derived images (first postcontrast subtracted …

Purpose To investigate the utility and accuracy of breast magnetic resonance (MR) imaging
as a supplemental screening tool in women at average risk for breast cancer and to …

The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA
organised a workshop in Milan on 20–21st October 2008 to evaluate the evidence currently …

Screening for breast cancer with mammography has been shown to decrease mortality from
breast cancer, and mammography is the mainstay of screening for clinically occult disease …

In the United States in 2017, an estimated 255,180 new breast cancer cases will be
diagnosed. 1 In 2013, breast cancer deaths totaled 773,100 person-years of life lost, with …

Purpose To determine feasibility of performing bilateral dual-energy (DE) contrast agent–
enhanced (CE) digital mammography and to evaluate its performance compared with …